SlideShare una empresa de Scribd logo

Pro strakan group plc – product pipeline review – 2012

•Descargar como DOCX, PDF•
•
R
Rose088

2012 Aarkstore.com || ProStrakan Group plc – Product Pipeline Review – 2012

Desarrollo personalEmpresariales
1 de 5
Aarkstore.com announces, The Latest market research report is available in its vast collection: ProStrakan Group plc – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/ProStrakan-Group-plc-Product-Pipeline- Review-2012-217952.html RSS link of Global Markets Direct http://www.aarkstore.com/feeds/Global-Markets-Direct.xml Summary Global Market Direct’s pharmaceuticals report, “ProStrakan Group plc - Product Pipeline Review - 2012” provides data on the ProStrakan Group plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ProStrakan Group plc’s corporate website, SEC filings, investor presentations and featured press releases, both from ProStrakan Group plc and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - ProStrakan Group plc - Brief ProStrakan Group plc overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of ProStrakan Group plc human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
Table of contents: List of Tables 5 List of Figures 6 ProStrakan Group plc Snapshot 7 ProStrakan Group plc Overview 7 Key Information 7 Key Facts 7 ProStrakan Group plc – Research and Development Overview 8 Key Therapeutic Areas 8 ProStrakan Group plc – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 ProStrakan Group plc – Pipeline Products Glance 12 ProStrakan Group plc – Late Stage Pipeline 12 Phase III Products/Combination Treatment Modalities 12 ProStrakan Group plc Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 ProStrakan Group plc – Drug Profiles 14 Abstral 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Sancuso 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 SyB D-0701 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Testosterone-Glucoside 18 Product Description 18 Mechanism of Action 18 R&D Progress 18
ProStrakan Group plc – Pipeline Analysis 19 ProStrakan Group plc – Pipeline Products by Therapeutic Class 19 ProStrakan Group plc – Pipeline Products By Target 21 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review&PubId=&pagenum=1 Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012 BIOALVO S.A. – Product Pipeline Review – 2012 Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Cardio3 BioSciences SA – Product Pipeline Review – 2012 Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012 iCo Therapeutics Inc. – Product Pipeline Review – 2012 Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012
Mersana Therapeutics, Inc. – Product Pipeline Review – 2012 Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012 Nuon Therapeutics, Inc. – Product Pipeline Review – 2012 Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012 SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012 ProStrakan Group plc – Product Pipeline Review – 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 You can also request for sample page of above mention reports on sample@aarkstore.com For More details Plz do contact : Aarkstore Enterprise Lavanya
Phone:08149852585 Email: enquiry@aarkstore.com

Recomendados

Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Rose088
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Rose088
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Rose088
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088
 

Recomendados

Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Rose088
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Rose088
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Rose088
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Rose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Rose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Rose088
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Rose088
 
Aprea ab – product pipeline review – 2012
Aprea ab – product pipeline review – 2012Aprea ab – product pipeline review – 2012
Aprea ab – product pipeline review – 2012Rose088
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Rose088
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 

Más contenido relacionado

La actualidad más candente

Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Rose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Rose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Rose088
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Rose088
 
Aprea ab – product pipeline review – 2012
Aprea ab – product pipeline review – 2012Aprea ab – product pipeline review – 2012
Aprea ab – product pipeline review – 2012Rose088
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Rose088
 

La actualidad más candente (20)

Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
 
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
 
Aprea ab – product pipeline review – 2012
Aprea ab – product pipeline review – 2012Aprea ab – product pipeline review – 2012
Aprea ab – product pipeline review – 2012
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012
 

Similar a Pro strakan group plc – product pipeline review – 2012

Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
Af fi ris ag – product pipeline review – 2012
Af fi ris ag – product pipeline review – 2012Af fi ris ag – product pipeline review – 2012
Af fi ris ag – product pipeline review – 2012Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Recoly n.v. – product pipeline review – 2012
Recoly n.v. – product pipeline review – 2012Recoly n.v. – product pipeline review – 2012
Recoly n.v. – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 

Similar a Pro strakan group plc – product pipeline review – 2012 (13)

Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
Af fi ris ag – product pipeline review – 2012
Af fi ris ag – product pipeline review – 2012Af fi ris ag – product pipeline review – 2012
Af fi ris ag – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Recoly n.v. – product pipeline review – 2012
Recoly n.v. – product pipeline review – 2012Recoly n.v. – product pipeline review – 2012
Recoly n.v. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 

Más de Rose088

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeRose088
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016Rose088
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Rose088
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineRose088
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Rose088
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionRose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Rose088
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 

Más de Rose088 (12)

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoption
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 

Último

English basic for beginners Future tenses .pdf
English basic for beginners Future tenses .pdfEnglish basic for beginners Future tenses .pdf
English basic for beginners Future tenses .pdfbromerom1
 
The 5 sec rule - Mel Robins (Hindi Summary)
The 5 sec rule - Mel Robins (Hindi Summary)The 5 sec rule - Mel Robins (Hindi Summary)
The 5 sec rule - Mel Robins (Hindi Summary)Shakti Savarn
 
Benefits of Co working & Shared office space in India
Benefits of Co working & Shared office space in IndiaBenefits of Co working & Shared office space in India
Benefits of Co working & Shared office space in IndiaBrantfordIndia
 
Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?
Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?
Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?Mikko Kangassalo
 
Call Girls Dubai O525547819 Favor Dubai Call Girls Agency
Call Girls Dubai O525547819 Favor Dubai Call Girls AgencyCall Girls Dubai O525547819 Favor Dubai Call Girls Agency
Call Girls Dubai O525547819 Favor Dubai Call Girls Agencykojalkojal131
 
integrity in personal relationship (1).pdf
integrity in personal relationship (1).pdfintegrity in personal relationship (1).pdf
integrity in personal relationship (1).pdfAmitRout25
 
Spiritual Life Quote from Shiva Negi
Spiritual Life Quote from Shiva Negi Spiritual Life Quote from Shiva Negi
Spiritual Life Quote from Shiva Negi OneDay18
 

Último (7)

English basic for beginners Future tenses .pdf
English basic for beginners Future tenses .pdfEnglish basic for beginners Future tenses .pdf
English basic for beginners Future tenses .pdf
 
The 5 sec rule - Mel Robins (Hindi Summary)
The 5 sec rule - Mel Robins (Hindi Summary)The 5 sec rule - Mel Robins (Hindi Summary)
The 5 sec rule - Mel Robins (Hindi Summary)
 
Benefits of Co working & Shared office space in India
Benefits of Co working & Shared office space in IndiaBenefits of Co working & Shared office space in India
Benefits of Co working & Shared office space in India
 
Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?
Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?
Virtue ethics & Effective Altruism: What can EA learn from virtue ethics?
 
Call Girls Dubai O525547819 Favor Dubai Call Girls Agency
Call Girls Dubai O525547819 Favor Dubai Call Girls AgencyCall Girls Dubai O525547819 Favor Dubai Call Girls Agency
Call Girls Dubai O525547819 Favor Dubai Call Girls Agency
 
integrity in personal relationship (1).pdf
integrity in personal relationship (1).pdfintegrity in personal relationship (1).pdf
integrity in personal relationship (1).pdf
 
Spiritual Life Quote from Shiva Negi
Spiritual Life Quote from Shiva Negi Spiritual Life Quote from Shiva Negi
Spiritual Life Quote from Shiva Negi
 

Pro strakan group plc – product pipeline review – 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: ProStrakan Group plc – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/ProStrakan-Group-plc-Product-Pipeline- Review-2012-217952.html RSS link of Global Markets Direct http://www.aarkstore.com/feeds/Global-Markets-Direct.xml Summary Global Market Direct’s pharmaceuticals report, “ProStrakan Group plc - Product Pipeline Review - 2012” provides data on the ProStrakan Group plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ProStrakan Group plc’s corporate website, SEC filings, investor presentations and featured press releases, both from ProStrakan Group plc and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - ProStrakan Group plc - Brief ProStrakan Group plc overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of ProStrakan Group plc human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • 2. Table of contents: List of Tables 5 List of Figures 6 ProStrakan Group plc Snapshot 7 ProStrakan Group plc Overview 7 Key Information 7 Key Facts 7 ProStrakan Group plc – Research and Development Overview 8 Key Therapeutic Areas 8 ProStrakan Group plc – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 ProStrakan Group plc – Pipeline Products Glance 12 ProStrakan Group plc – Late Stage Pipeline 12 Phase III Products/Combination Treatment Modalities 12 ProStrakan Group plc Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 ProStrakan Group plc – Drug Profiles 14 Abstral 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Sancuso 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 SyB D-0701 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Testosterone-Glucoside 18 Product Description 18 Mechanism of Action 18 R&D Progress 18
  • 3. ProStrakan Group plc – Pipeline Analysis 19 ProStrakan Group plc – Pipeline Products by Therapeutic Class 19 ProStrakan Group plc – Pipeline Products By Target 21 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review&PubId=&pagenum=1 Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012 BIOALVO S.A. – Product Pipeline Review – 2012 Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Cardio3 BioSciences SA – Product Pipeline Review – 2012 Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012 iCo Therapeutics Inc. – Product Pipeline Review – 2012 Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012
  • 4. Mersana Therapeutics, Inc. – Product Pipeline Review – 2012 Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012 Nuon Therapeutics, Inc. – Product Pipeline Review – 2012 Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012 SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012 ProStrakan Group plc – Product Pipeline Review – 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 You can also request for sample page of above mention reports on sample@aarkstore.com For More details Plz do contact : Aarkstore Enterprise Lavanya